SEC Form SC 13G/A filed by Annexon Inc. (Amendment)

2/14/24 8:46:41 PM ET

$ANNX

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $ANNX alert in real time by email

SC 13G/A 1 tm246235d12_sc13ga.htm SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G/A

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)*

Annexon, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

03589W102

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 03589W102

Page 2 of 17


1.	Name of reporting persons Venrock Healthcare Capital Partners II, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 0
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 0.0%
12.	Type of Reporting Person (See Instructions) PN

Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management II, LLC, VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

CUSIP No. 03589W102

Page 3 of 17


1.	Name of reporting persons VHCP Co-Investment Holdings II, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 0
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 0.0%
12.	Type of Reporting Person (See Instructions) OO

CUSIP No. 03589W102

Page 4 of 17


1.	Name of reporting persons Venrock Healthcare Capital Partners III, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 968,679²
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 968,679²
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 968,679²
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 1.2%³
12.	Type of Reporting Person (See Instructions) PN

This percentage is calculated based upon the sum of (i) 78,338,098 shares of common stock outstanding as of December 26, 2023 as disclosed in the Issuer’s prospectus supplement dated December 20, 2023 filed with the Securities and Exchange Commission on December 21, 2023 and (ii) 968,679 shares issuable upon exercise of warrants held by the Reporting Persons.

CUSIP No. 03589W102

Page 5 of 17


1.	Name of reporting persons VHCP Co-Investment Holdings III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 968,679²
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 968,679²
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 968,679²
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 1.2%³
12.	Type of Reporting Person (See Instructions) OO

CUSIP No. 03589W102

Page 6 of 17


1.	Name of reporting persons Venrock Healthcare Capital Partners EG, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 968,679²
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 968,679²
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 968,679²
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 1.2%³
12.	Type of Reporting Person (See Instructions) PN

CUSIP No. 03589W102

Page 7 of 17


1.	Name of reporting persons VHCP Management II, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 0
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 0.0%
12.	Type of Reporting Person (See Instructions) OO

CUSIP No. 03589W102

Page 8 of 17


1.	Name of reporting persons VHCP Management III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 968,679²
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 968,679²
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 968,679²
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 1.2%³
12.	Type of Reporting Person (See Instructions) OO

CUSIP No. 03589W102

Page 9 of 17


1.	Name of reporting persons VHCP Management EG, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 968,679²
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 968,679²
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 968,679²
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 1.2%³
12.	Type of Reporting Person (See Instructions) OO

CUSIP No. 03589W102

Page 10 of 17


1.	Name of Reporting Persons Shah, Nimish
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 968,679²
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 968,679²
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 968,679²
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 1.2%³
12.	Type of Reporting Person (See Instructions) IN

CUSIP No. 03589W102

Page 11 of 17


1.	Name of Reporting Persons Koh, Bong
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x¹(b) ¨
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 968,679²
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 968,679²
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 968,679²
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 1.2%³
12.	Type of Reporting Person (See Instructions) IN

CUSIP No. 03589W102

Page 12 of 17

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II LP”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment II”), Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment III”), Venrock Healthcare Capital Partners EG, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP EG”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II”), VHCP Management III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management III”), VHCP Management EG, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management EG” and collectively with VHCP II LP, VHCP Co-Investment II, VHCP III LP, VHCP Co-Investment III, VHCP EG, VHCP Management II and VHCP Management III, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect of the common stock of Annexon, Inc.

Item 1.

(a)

Name of Issuer

Annexon, Inc.

(b)

Address of Issuer’s Principal Executive Offices

1400 Sierra Point Parkway, Bldg C, Suite 200

Brisbane, California 94005

Item 2.

(a)

Name of Person Filing

Venrock Healthcare Capital Partners II, L.P.

VHCP Co-Investment Holdings II, LLC

Venrock Healthcare Capital Partners III, L.P.

VHCP Co-Investment Holdings III, LLC

Venrock Healthcare Capital Partners EG, L.P.

VHCP Management II, LLC

VHCP Management III, LLC

VHCP Management EG, LLC

Nimish Shah

Bong Koh

(b)

Address of Principal Business Office or, if none, Residence

	New York Office:	Palo Alto Office:

	7 Bryant Park	3340 Hillview Avenue
	23rd Floor	Palo Alto, CA 94304
	New York, NY 10018

(c)

Citizenship

All of the Venrock Entities were organized in Delaware. The individuals are both United States citizens.

CUSIP No. 03589W102

Page 13 of 17

(d)

Title of Class of Securities

Common Stock, par value $0.001 per share

(e)

CUSIP Number

03589W102

Item 3.

If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

Item 4.

Ownership

(a)

Amount Beneficially Owned as of December 31, 2023:

Venrock Healthcare Capital Partners II, L.P.	0
VHCP Co-Investment Holdings II, LLC	0
Venrock Healthcare Capital Partners III, L.P.	968,679	(1)
VHCP Co-Investment Holdings III, LLC	968,679	(1)
Venrock Healthcare Capital Partners EG, L.P.	968,679	(1)
VHCP Management II, LLC	0
VHCP Management III, LLC	968,679	(1)
VHCP Management EG, LLC	968,679	(1)
Nimish Shah	968,679	(1)
Bong Koh	968,679	(1)

(b)

Percent of Class as of December 31, 2023:

Venrock Healthcare Capital Partners II, L.P.	0.0	%
VHCP Co-Investment Holdings II, LLC	0.0	%
Venrock Healthcare Capital Partners III, L.P.	1.2	%
VHCP Co-Investment Holdings III, LLC	1.2	%
Venrock Healthcare Capital Partners EG, L.P.	1.2	%
VHCP Management II, LLC	0.0	%
VHCP Management III, LLC	1.2	%
VHCP Management EG, LLC	1.2	%
Nimish Shah	1.2	%
Bong Koh	1.2	%

(c)

Number of shares as to which the person has, as of December 31, 2023:

(i)

Sole power to vote or to direct the vote

Venrock Healthcare Capital Partners II, L.P.			0
VHCP Co-Investment Holdings II, LLC			0
Venrock Healthcare Capital Partners III, L.P.			0
VHCP Co-Investment Holdings III, LLC			0
Venrock Healthcare Capital Partners EG, L.P.			0
VHCP Management II, LLC			0
VHCP Management III, LLC			0
VHCP Management EG, LLC			0
Nimish Shah			0
Bong Koh			0

CUSIP No. 03589W102

Page 14 of 17

(ii)

Shared power to vote or to direct the vote

Venrock Healthcare Capital Partners II, L.P.	0
VHCP Co-Investment Holdings II, LLC	0
Venrock Healthcare Capital Partners III, L.P.	968,679	(1)
VHCP Co-Investment Holdings III, LLC	968,679	(1)
Venrock Healthcare Capital Partners EG, L.P.	968,679	(1)
VHCP Management II, LLC	0
VHCP Management III, LLC	968,679	(1)
VHCP Management EG, LLC	968,679	(1)
Nimish Shah	968,679	(1)
Bong Koh	968,679	(1)

(iii)

Sole power to dispose or to direct the disposition of

Venrock Healthcare Capital Partners II, L.P.			0
VHCP Co-Investment Holdings II, LLC			0
Venrock Healthcare Capital Partners III, L.P.			0
VHCP Co-Investment Holdings III, LLC			0
Venrock Healthcare Capital Partners EG, L.P.			0
VHCP Management II, LLC			0
VHCP Management III, LLC			0
VHCP Management EG, LLC			0
Nimish Shah			0
Bong Koh			0

(iv)

Shared power to dispose or to direct the disposition of

Venrock Healthcare Capital Partners II, L.P.	0
VHCP Co-Investment Holdings II, LLC	0
Venrock Healthcare Capital Partners III, L.P.	968,679	(1)
VHCP Co-Investment Holdings III, LLC	968,679	(1)
Venrock Healthcare Capital Partners EG, L.P.	968,679	(1)
VHCP Management II, LLC	0
VHCP Management III, LLC	968,679	(1)
VHCP Management EG, LLC	968,679	(1)
Nimish Shah	968,679	(1)
Bong Koh	968,679	(1)

(1)

Consists of (i) 254,666 shares issuable upon the exercise of immediately exercisable warrants held by Venrock Healthcare Capital Partners III, L.P., (ii) 25,476 shares issuable upon the exercise of immediately exercisable warrants held by VHCP Co-Investment Holdings III, LLC and (iii) 688,537 shares issuable upon the exercise of immediately exercisable warrants held by Venrock Healthcare Capital Partners EG, L.P. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. VHCP Management EG, LLC is the general partner of Venrock Healthcare Capital Partners EG, L.P. Messrs. Shah and Koh are the voting members of VHCP Management II, LLC, VHCP Management III, LLC and VHCP Management EG, LLC.

CUSIP No. 03589W102

Page 15 of 17

Item 5.	Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group

Not Applicable

Item 9.

Notice of Dissolution of a Group

Not Applicable

Item 10.

Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

CUSIP No. 03589W102

Page 16 of 17

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2024

Venrock Healthcare Capital Partners II, L.P.			Venrock Healthcare Capital Partners III, L.P.

By:	VHCP Management II, LLC		By:	VHCP Management III, LLC
Its:	General Partner		Its:	General Partner

By:	/s/ Sherman G. Souther		By:	/s/ Sherman G. Souther
	Name:	Sherman G. Souther		Name:	Sherman G. Souther
	Its:	Authorized Signatory		Its:	Authorized Signatory

VHCP Co-Investment Holdings II, LLC			VHCP Co-Investment Holdings III, LLC

By:	VHCP Management II, LLC		By:	VHCP Management III, LLC
Its:	Manager		Its:	Manager

By:	/s/ Sherman G. Souther		By:	/s/ Sherman G. Souther
	Name:	Sherman G. Souther		Name:	Sherman G. Souther
	Its:	Authorized Signatory		Its:	Authorized Signatory

VHCP Management II, LLC			VHCP Management III, LLC

By:	/s/ Sherman G. Souther		By:	/s/ Sherman G. Souther
	Name:	Sherman G. Souther		Name:	Sherman G. Souther
	Its:	Authorized Signatory		Its:	Authorized Signatory

Venrock Healthcare Capital Partners EG, L.P.			VHCP Management EG, LLC

By:	VHCP Management EG, LLC		/s/ Sherman G. Souther
Its:	General Partner		Name:	Sherman G. Souther
			Its:	Authorized Signatory
/s/ Sherman G. Souther
Name:	Sherman G. Souther
Its:	Authorized Signatory

Bong Koh

/s/ Sherman G. Souther
Sherman G. Souther, Attorney-in-fact

Nimish Shah

/s/ Sherman G. Souther
Sherman G. Souther, Attorney-in-fact

CUSIP No. 03589W102

Page 17 of 17

EXHIBITS

Joint Filing Agreement (incorporated by reference to Exhibit A to Schedule 13G filed on June 23, 2022)

Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to Schedule 13G filed on June 23, 2022)

Power of Attorney for Bong Koh (incorporated by reference to Exhibit B to Schedule 13G filed on June 23, 2022)

Get the next $ANNX alert in real time by email

Date	Price Target	Rating	Analyst
3/1/2024	$11.00	Neutral → Overweight	JP Morgan
12/21/2023	$4.00 → $6.00	Neutral → Buy	BofA Securities
10/30/2023	$11.00	Overweight	Wells Fargo
5/26/2023	$8.00 → $3.00	Buy → Neutral	BofA Securities
5/25/2023	$19.00 → $9.00	Overweight → Neutral	JP Morgan
9/16/2022	$12.00	Buy	Jefferies
9/9/2022	$15.00	Buy	BTIG Research
11/30/2021	$40.00	Buy	HC Wainwright & Co.

SEC Form SC 13G/A filed by Annexon Inc. (Amendment)

Chat with this insight

Recent Analyst Ratings for $ANNX

$ANNX Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Annexon upgraded by JP Morgan with a new price target

Annexon upgraded by BofA Securities with a new price target

Wells Fargo initiated coverage on Annexon with a new price target

$ANNX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EVP & CHIEF SCIENTIFIC OFFICER Artis Dean Richard was granted 44,963 shares, increasing direct ownership by 54% to 128,777 units (SEC Form 4)

CHIEF MEDICAL OFFICER Dananberg Jamie was granted 44,963 shares, increasing direct ownership by 134% to 78,442 units (SEC Form 4)

EVP & CHIEF FINANCIAL OFFICER Lew Jennifer was granted 44,963 shares, increasing direct ownership by 58% to 122,733 units (SEC Form 4)

$ANNX SEC Filings

SEC Form 10-Q filed by Annexon Inc.

Annexon Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Amendment: SEC Form SCHEDULE 13G/A filed by Annexon Inc.

$ANNX Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Annexon Inc.

Amendment: SEC Form SC 13G/A filed by Annexon Inc.

Amendment: SEC Form SC 13G/A filed by Annexon Inc.

$ANNX Financials

Live finance-specific insights

$ANNX Press Releases

Fastest customizable press release news feed in the world

$ANNX Leadership Updates

Live Leadership Updates

Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)

Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome

Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data

Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors

Annexon Expands Board of Directors with Appointment of Commercial Executive William "BJ" Jones

Annexon Expands Senior Leadership in Commercial, Medical Affairs and Health Economics to Advance Global Late-Stage Neuroinflammatory-Targeted Portfolio

$ANNX Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Carson William H. bought $17,056 worth of shares (3,200 units at $5.33), increasing direct ownership by 14% to 25,600 units (SEC Form 4)

Director Carson William H. bought $19,104 worth of shares (3,200 units at $5.97), increasing direct ownership by 17% to 22,400 units (SEC Form 4)

Director Carson William H. bought $17,536 worth of shares (3,200 units at $5.48), increasing direct ownership by 20% to 19,200 units (SEC Form 4)

Recent Analyst Ratings for
$ANNX

$ANNX
Analyst Ratings

$ANNX
Insider Trading

$ANNX
SEC Filings

$ANNX
Large Ownership Changes

$ANNX
Financials

$ANNX
Press Releases

$ANNX
Leadership Updates

$ANNX
Insider Purchases